The Enterprise Value as of November 2025 (TTM) for Revance Therapeutics, Inc. (RVNC) is 805.89M

According to Revance Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 805.89M. This represents a change of -9.27% compared to the average of 888.23M of the last 4 quarters.

Revance Therapeutics, Inc. (RVNC) Historical Enterprise Value (quarterly & annually)

How has RVNC Enterprise Value performed in the past?

The mean historical Enterprise Value of Revance Therapeutics, Inc. over the last ten years is 891.10M. The current 805.89M Enterprise Value has changed 8.94% with respect to the historical average. Over the past ten years (40 quarters), RVNC's Enterprise Value was at its highest in in the March 2023 quarter at 2.91B. The Enterprise Value was at its lowest in in the December 2014 quarter at 230.47M.

Revance Therapeutics, Inc. (RVNC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Revance Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Revance Therapeutics, Inc. (RVNC) Average Enterprise Value

How has RVNC Enterprise Value performed in the past?

The current Enterprise Value of Revance Therapeutics, Inc. (RVNC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Revance Therapeutics, Inc. (RVNC) Enterprise Value vs. Peers

How is RVNC’s Enterprise Value compared to its peers?

Revance Therapeutics, Inc.’s Enterprise Value is greater than Orchard Therapeutics plc (369.77M), greater than G1 Therapeutics, Inc. (402.64M), greater than Vigil Neuroscience, Inc. (346.93M), greater than Checkpoint Therapeutics, Inc. (334.68M), greater than Y-mAbs Therapeutics, Inc. (332.06M), greater than Climb Bio, Inc. (95.92M), greater than iTeos Therapeutics, Inc. (245.99M), less than Claritev Corporation (5.15B), greater than Big Cypress Acquisition Corp. (402.12M), greater than SomaLogic, Inc. (-23127083.00),

Build a custom stock screener for Revance Therapeutics, Inc. (RVNC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revance Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revance Therapeutics, Inc. (RVNC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revance Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.